111 related articles for article (PubMed ID: 2077396)
1. Estrogen receptor concentration and social factors as predictors of natural killer cell activity in early-stage breast cancer patients. Confirmation of a model.
Levy SM; Herberman RB; Lee J; Whiteside T; Kirkwood J; McFeeley S
Nat Immun Cell Growth Regul; 1990; 9(5):313-24. PubMed ID: 2077396
[TBL] [Abstract][Full Text] [Related]
2. Immunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancer.
Levy SM; Herberman RB; Lippman M; D'Angelo T; Lee J
Behav Med; 1991; 17(2):67-75. PubMed ID: 1878611
[TBL] [Abstract][Full Text] [Related]
3. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
4. Social support, psychological distress, and natural killer cell activity in ovarian cancer.
Lutgendorf SK; Sood AK; Anderson B; McGinn S; Maiseri H; Dao M; Sorosky JI; De Geest K; Ritchie J; Lubaroff DM
J Clin Oncol; 2005 Oct; 23(28):7105-13. PubMed ID: 16192594
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis.
Takeuchi H; Maehara Y; Tokunaga E; Koga T; Kakeji Y; Sugimachi K
Am J Gastroenterol; 2001 Feb; 96(2):574-8. PubMed ID: 11232710
[TBL] [Abstract][Full Text] [Related]
6. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
7. [Steroid receptors and NK cell activity in patients with breast cancer].
Konjević G; Branković-Magić M; Nikolić-Vukosavljević D; Spuzić I
Srp Arh Celok Lek; 1994; 122(5-6):139-42. PubMed ID: 17977410
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation.
Haffty BG; Yang Q; Moran MS; Tan AR; Reiss M
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1006-13. PubMed ID: 18262731
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of estrogen receptor status as assessed by ligand-binding assay in patients with early-stage breast cancer treated with breast conserving surgery and radiation therapy.
Takei H; Horiguchi J; Maemura M; Koibuchi Y; Oyama T; Yokoe T; Iino Y; Morishita Y
Oncol Rep; 2002; 9(2):375-8. PubMed ID: 11836611
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer and neoadjuvant therapy: any predictive marker?
Vyzula R; Dusek L; Zaloudík J; Demlová R; Klimes D; Selvekerová S
Neoplasma; 2004; 51(6):471-80. PubMed ID: 15640958
[TBL] [Abstract][Full Text] [Related]
11. Immune responses to guided imagery during breast cancer treatment.
Lengacher CA; Bennett MP; Gonzalez L; Gilvary D; Cox CE; Cantor A; Jacobsen PB; Yang C; Djeu J
Biol Res Nurs; 2008 Jan; 9(3):205-14. PubMed ID: 18077773
[TBL] [Abstract][Full Text] [Related]
12. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.
Ignatiadis M; Xenidis N; Perraki M; Apostolaki S; Politaki E; Kafousi M; Stathopoulos EN; Stathopoulou A; Lianidou E; Chlouverakis G; Sotiriou C; Georgoulias V; Mavroudis D
J Clin Oncol; 2007 Nov; 25(33):5194-202. PubMed ID: 17954712
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
14. Perceived social support and tumor estrogen/progesterone receptor status as predictors of natural killer cell activity in breast cancer patients.
Levy SM; Herberman RB; Whiteside T; Sanzo K; Lee J; Kirkwood J
Psychosom Med; 1990; 52(1):73-85. PubMed ID: 2305024
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer.
Thorpe SM; Rose C; Rasmussen BB; Mouridsen HT; Bayer T; Keiding N
Cancer Res; 1987 Nov; 47(22):6126-33. PubMed ID: 3664512
[TBL] [Abstract][Full Text] [Related]
16. Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer.
Scorilas A; Talieri M; Ardavanis A; Courtis N; Dimitriadis E; Yotis J; Tsiapalis CM; Trangas T
Cancer Res; 2000 Oct; 60(19):5427-33. PubMed ID: 11034084
[TBL] [Abstract][Full Text] [Related]
17. [The possibilities of modulation of NK cell activity].
Konjević G; Spuzić I
Glas Srp Akad Nauka Med; 2002; (47):89-101. PubMed ID: 16078444
[TBL] [Abstract][Full Text] [Related]
18. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
19. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
[TBL] [Abstract][Full Text] [Related]
20. Model for breast cancer survival: relative prognostic roles of axillary nodal status, TNM stage, estrogen receptor concentration, and tumor necrosis.
Shek LL; Godolphin W
Cancer Res; 1988 Oct; 48(19):5565-9. PubMed ID: 3416309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
